KPTIQ Karyopharm Therapeutics Inc.

Fundamentals / CIK 0001503802 / USD
Other share classes on CIK 0001503802: KPTI

Karyopharm Therapeutics Inc. reported $146.6M in revenue and a net loss of $224.7M for the trailing twelve months ended June 30, 2026 (down 11.9% year over year), with a -56.2% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open KPTIQ in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$227.9M$113.9M$0-$204.5MFY 2016 Revenue: $154KFY 2016 Net Income: -$109.6M2016FY 2017 Revenue: $1.60MFY 2017 Net Income: -$129.0M2017FY 2018 Revenue: $30.34MFY 2018 Net Income: -$178.4M2018FY 2019 Revenue: $40.89MFY 2019 Net Income: -$199.6M2019FY 2020 Revenue: $108.1MFY 2020 Net Income: -$196.3M2020FY 2021 Revenue: $209.8MFY 2021 Net Income: -$124.1M2021FY 2022 Revenue: $157.1MFY 2022 Net Income: -$165.3M2022FY 2023 Revenue: $146.0MFY 2023 Net Income: -$143.1M2023FY 2024 Revenue: $145.2MFY 2024 Net Income: -$76.42M2024FY 2025 Revenue: $146.1MFY 2025 Net Income: -$196.0M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $146.1M $145.2M $146.0M $157.1M $209.8M $108.1M $40.89M $30.34M $1.60M $154K
Research & Development $125.6M $143.2M $138.8M $148.7M $160.8M $150.8M $122.3M $161.4M $107.3M $86.94M
Selling, General & Admin $105.2M $115.4M $131.9M $145.4M $143.8M $126.4M $105.4M $48.85M $24.87M --
Total Operating Expenses $236.8M $264.7M $275.6M $299.3M $308.1M $279.9M $230.2M $210.2M $132.1M $110.9M
Operating Income -$90.71M -$119.4M -$129.5M -$142.2M -$98.27M -$171.8M -$189.3M -$179.9M -$130.5M -$110.7M
EBITDA -$90.41M -$119.1M -$129.0M -$141.6M -$97.48M -$170.9M -$188.3M -$179.1M -$129.8M -$110.0M
Interest Income $2.77M $7.40M $10.94M $2.36M $582K $2.82M $5.42M $4.03M $1.70M $1.28M
Interest Expense $45.85M $37.42M $23.82M $25.00M $26.05M $27.14M $15.65M $2.49M -- --
Income Before Tax -$196.0M -$76.36M -$142.8M -$164.9M -$123.8M -$196.0M -$199.6M -$178.4M -$128.9M -$109.4M
Income Tax Expense $43K $57K $323K $369K $268K $309K $40K $26K $63K $139K
Net Income -$196.0M -$76.42M -$143.1M -$165.3M -$124.1M -$196.3M -$199.6M -$178.4M -$129.0M -$109.6M
Basic EPS -$17.93 -$9.41 -$18.79 -$30.30 -$24.75 -$40.80 -$48.30 -$47.10 -$42.15 -$43.80
Diluted EPS -$17.93 -$14.00 -$18.79 -$30.30 -$24.75 -$40.80 -$48.30 -$47.10 -$42.15 -$43.80
Basic Shares Outstanding 10.9K 8.1K 7.6K 5.5K 5.0M 4.8M 4.1M 3.8K 3.1M 2.5M
Diluted Shares Outstanding 10.9K 8.5K 7.6K 5.5K 5.0M 4.8M 4.1M 3.8K 3.1M 2.5M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue $33.43M $35.07M $34.08M $44.04M $37.93M $30.02M $30.54M $38.78M
Research & Development $28.96M $33.80M $27.67M $30.54M $32.79M $34.62M $33.30M $36.13M
Selling, General & Admin $25.92M $26.68M $22.77M $26.61M $28.48M $27.35M $27.19M $27.63M
Total Operating Expenses $55.96M $61.83M $51.92M $59.26M $62.32M $63.27M $61.82M $65.07M
Operating Income -$22.53M -$26.76M -$17.84M -$15.22M -$24.39M -$33.26M -$31.28M -$26.28M
EBITDA -$22.53M -$26.75M -$17.82M -$15.10M -$24.31M -$33.18M -$31.20M -$26.20M
Interest Income $722K $511K $607K $553K $613K $1.00M $1.48M $1.83M
Interest Expense $13.14M $12.55M $12.62M $11.01M $11.23M $10.99M $11.20M $11.38M
Income Before Tax -$67.02M -$22.39M -$102.3M -$33.09M -$37.21M -$23.43M -$30.89M -$32.04M
Income Tax Expense $0 $1.0K -$67K $34K $40K $36K -$109K $28K
Net Income -$67.02M -$22.39M -$102.2M -$33.13M -$37.25M -$23.46M -$30.78M -$32.07M
Basic EPS -$2.32 -$1.02 -- -$3.82 -$4.32 -$2.77 -- -$3.85
Diluted EPS -$2.32 -$1.24 -- -$3.82 -$4.32 -$2.77 -- -$3.85
Basic Shares Outstanding 28.9K 22.0K -- 8.7K 8.6K 8.5K -- 8.3K
Diluted Shares Outstanding 28.9K 24.7K -- 8.7K 8.6K 8.5K -- 8.3K

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $60.54M $62.48M $52.23M $135.2M $190.5M $85.92M $128.9M $118.0M $69.00M $49.66M
Short-Term Investments $3.20M $46.24M $139.2M $142.8M $38.16M $163.3M $133.1M $210.2M $77.47M $79.89M
Cash & Short-Term Investments $63.70M $108.7M $191.4M $278.0M $228.6M $249.2M $262.0M $328.2M $146.5M $129.6M
Accounts Receivable, Net $26.18M $30.77M $26.96M $47.09M $22.50M $12.88M $7.86M -- -- --
Inventory $4.04M $4.74M $3.04M $4.22M $4.11M $2.64M $346K -- -- --
Other Current Assets -- -- -- -- $1.53M -- -- -- -- --
Total Current Assets $103.1M $156.5M $233.9M $350.2M $275.6M $276.5M $278.6M $334.6M $148.4M $131.6M
Property, Plant & Equipment, Net $104K $400K $606K $1.14M $1.64M $2.22M $3.05M $3.86M $2.19M $2.84M
Long-Term Investments -- -- -- -- -- $24.21M $2.02M $2.00M $29.40M $45.43M
Total Non-Current Assets $5.27M $7.96M $6.52M $8.01M $29.70M $36.52M $16.39M $6.58M $31.87M $48.75M
Total Assets $108.4M $164.4M $240.4M $358.2M $305.3M $313.1M $295.0M $341.2M $180.3M $180.4M
Accounts Payable $4.00M $5.11M $3.12M $2.77M $1.60M $4.45M $985K $4.33M $5.67M $4.75M
Deferred Revenue (Current) -- -- -- -- -- $297K $2.34M $9.36M $21.92M --
Other Current Liabilities $1.58M $1.64M $1.65M $1.85M $678K $609K $500K $327K $133K $83K
Total Current Liabilities $92.06M $92.26M $69.48M $65.91M $73.72M $60.20M $46.35M $46.90M $49.47M $16.48M
Long-Term Debt -- -- -- -- $169.3M -- -- -- -- --
Deferred Revenue (Non-Current) -- -- -- -- -- $0 $2.19M $4.53M -- --
Other Non-Current Liabilities $11.10M $2.43M $978K $0 -- -- -- -- -- --
Total Non-Current Liabilities $309.3M $258.2M $307.2M $308.9M $311.3M $202.3M $198.8M $111.1M $1.36M $1.67M
Total Liabilities $401.3M $350.4M $376.6M $374.8M $385.0M $262.5M $245.2M $158.0M $50.83M $18.14M
Total Debt (incl. Leases) $6.71M $7.15M $6.10M $8.97M $180.6M $13.20M $14.85M -- -- --
Common Stock $14K $13K $12K $12K $8.0K $7.0K $7.0K $6.0K $5.0K $4.0K
Retained Earnings -$1.76B -$1.56B -$1.49B -$1.34B -$1.18B -$1.07B -$873.3M -$673.7M -$495.3M -$366.1M
Accumulated Other Comp. Income $71K -$356K -$161K -$638K $191K $518K -$37K -$244K -$217K -$274K
Total Stockholders' Equity -$292.9M -$186.0M -$136.2M -$16.66M -$79.67M $50.55M $49.77M $183.2M $129.5M $162.2M
Total Equity -$292.9M -$186.0M -$136.2M -$16.66M -$79.67M $50.55M $49.77M $183.2M $129.5M $162.2M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Cash & Cash Equivalents $54.98M $90.85M $60.54M $37.67M $38.73M $38.78M $62.48M $72.83M
Short-Term Investments $10.12M $0 $3.20M $8.21M $12.97M $31.16M $46.24M $60.70M
Cash & Short-Term Investments $65.10M $90.90M $63.70M $45.90M $51.70M $69.90M $108.7M $133.5M
Accounts Receivable, Net $29.87M $23.36M $26.18M $31.88M $32.93M $35.24M $30.77M $31.78M
Inventory $3.99M $3.60M $4.04M $3.97M $4.99M $4.77M $4.74M $4.67M
Total Current Assets $106.4M $126.3M $103.1M $89.75M $97.87M $120.2M $156.5M $184.8M
Property, Plant & Equipment, Net $94K $91K $104K $122K $244K $322K $400K $495K
Total Non-Current Assets $4.94M $5.08M $5.27M $6.49M $7.01M $7.47M $7.96M $4.72M
Total Assets $111.3M $131.4M $108.4M $96.23M $104.9M $127.7M $164.4M $189.5M
Accounts Payable $7.66M $4.28M $4.00M $5.39M $2.60M $5.87M $5.11M $5.78M
Other Current Liabilities $6.39M $3.47M $1.58M $1.76M $1.57M $1.94M $1.64M $1.94M
Total Current Liabilities $134.2M $117.3M $92.06M $87.16M $99.22M $90.37M $92.26M $61.49M
Other Non-Current Liabilities $336K $278K $11.10M $14.12M $8.26M $5.15M $2.43M $6.18M
Total Non-Current Liabilities $307.3M $279.8M $309.3M $278.3M $244.6M $243.2M $258.2M $287.6M
Total Liabilities $441.5M $397.1M $401.3M $365.5M $343.8M $333.6M $350.4M $349.1M
Total Debt (incl. Leases) $6.25M $6.49M $6.71M $6.93M $7.63M $7.41M $7.15M $3.67M
Common Stock $14K $14K $14K $13K $13K $13K $13K $13K
Retained Earnings -$1.85B -$1.78B -$1.76B -$1.66B -$1.62B -$1.59B -$1.56B -$1.53B
Accumulated Other Comp. Income $41K $43K $71K -$259K -$251K -$321K -$356K -$222K
Total Stockholders' Equity -$330.2M -$265.6M -$292.9M -$269.3M -$238.9M -$205.9M -$186.0M -$159.6M
Total Equity -$330.2M -$265.6M -$292.9M -$269.3M -$238.9M -$205.9M -$186.0M -$159.6M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$196.0M -$76.42M -$143.1M -$165.3M -$124.1M -$196.3M -$199.6M -$178.4M -$129.0M -$109.6M
Depreciation & Amortization $296K $340K $530K $621K $789K $972K $974K $735K $713K $717K
Stock-Based Compensation $14.05M $18.43M $21.71M $35.40M $29.78M $24.41M $15.29M $17.27M $20.41M $22.28M
Change in Receivables $4.59M -$3.80M $20.12M -$5.08M -$9.62M -$5.02M -$7.86M -- -- --
Change in Inventory $701K -$1.70M $1.18M -$118K -$1.46M -$2.63M -$346K -- -- --
Change in Payables -$1.10M $1.98M $350K $1.17M -$2.85M $3.46M -$3.30M -$1.38M $909K $945K
Operating Cash Flow -$75.37M -$127.5M -$92.72M -$149.6M -$107.1M -$160.2M -$190.8M -$159.1M -$73.72M -$84.39M
Capital Expenditure $0 -$142K $0 -$118K -$212K -$145K -$206K -$2.36M -$62K -$70K
Free Cash Flow -$75.37M -$127.6M -$92.72M -$149.7M -$107.3M -$160.4M -$191.0M -$161.5M -$73.78M -$84.46M
Purchases of Investments $0 -$58.82M -$159.2M -$226.0M -$45.23M -$274.6M -$178.5M -$242.8M -$98.37M -$134.7M
Sales & Maturities of Investments -- -- -- -- -- -- -- -- $115.5M $159.4M
Investing Cash Flow $43.38M $95.47M $7.94M -$104.3M $141.8M -$53.69M $78.45M -$107.7M $17.11M $24.59M
Financing Cash Flow $30.05M $41.65M $1.12M $193.7M $73.65M $172.1M $124.3M $316.1M $75.74M $51.16M
Net Change in Cash -$1.92M $9.62M -$83.69M -$60.56M $108.3M -$41.57M $11.95M $49.25M $19.34M -$8.70M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Net Income -$67.02M -$22.39M -$102.2M -$33.13M -$37.25M -$23.46M -$30.78M -$32.07M
Depreciation & Amortization -$3.0K $12K $19K $121K $78K $78K $81K $83K
Stock-Based Compensation $1.93M $3.01M $3.90M $2.80M $3.78M $3.56M $3.86M $4.18M
Change in Receivables -$6.51M $2.82M $5.70M $1.05M $2.31M -$4.48M $1.01M $6.22M
Change in Inventory -$395K $439K -$72K $1.03M -$223K -$30K -$67K -$1.20M
Change in Payables $3.38M $276K -$1.39M $2.79M -$3.27M $765K -$676K $2.99M
Operating Cash Flow -$24.93M -$22.73M -$11.83M -$5.86M -$18.70M -$38.98M -$25.81M -$19.45M
Capital Expenditure -- -- $0 $0 $0 $0 $53K $0
Free Cash Flow -- -- -$11.83M -$5.86M -$18.70M -$38.98M -$25.76M -$19.45M
Purchases of Investments -- -- $0 $0 $0 $0 -$1.51M -$20.80M
Investing Cash Flow -$10.04M $3.20M $5.00M $4.80M $18.29M $15.29M $14.80M $7.47M
Common Stock Issued $0 $20.23M -- -- $0 $0 -- --
Financing Cash Flow -$898K $49.80M $29.69M $0 $356K $0 -- --
Net Change in Cash -$35.87M $30.28M $22.87M -$1.05M -$48K -$23.69M -$10.35M -$11.94M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -62.1% -82.2% -88.7% -90.5% -46.8% -159.0% -462.9% -593.0% -8133.2% -71903.9%
Net Profit Margin -134.2% -52.6% -98.0% -105.2% -59.1% -181.6% -488.1% -588.1% -8036.4% -71153.9%
Return on Equity (ROE) -- -- -- -- -- -388.3% -401.0% -97.4% -99.6% -67.5%
Return on Assets (ROA) -180.8% -46.5% -59.5% -46.1% -40.6% -62.7% -67.7% -52.3% -71.5% -60.7%
Current Ratio 1.12x 1.70x 3.37x 5.31x 3.74x 4.59x 6.01x 7.13x 3.00x 7.99x
Quick Ratio 1.08x 1.64x 3.32x 5.25x 3.68x 4.55x 6.00x 7.00x 2.96x 7.86x
Debt to Equity -- -- -- -- -- 0.26x 0.30x -- -- --
Revenue Growth (YoY) +0.6% -0.5% -7.0% -25.1% +94.1% +164.3% +34.8% +1790.1% +942.2% -38.4%
5Y Revenue / Share Growth +59257.3% +180446.9% +139.2% +5486650.0% +67867.4% +21275.5% +8874.2% +837647.0% -90.2% -97.3%
10Y Revenue / Share Growth +12687807.3% +16202537.8% +2004116.0% +537139.7% +1742.8% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Operating Margin -56.2% -55.7% -62.1% -73.1% -83.9% -83.7% -82.2% -84.9%
Net Profit Margin -153.3% -129.0% -134.2% -87.4% -90.0% -44.0% -52.6% -58.9%
Return on Assets (ROA) -201.9% -148.4% -180.8% -129.5% -117.8% -49.0% -46.5% -46.2%
Current Ratio 0.79x 1.08x 1.12x 1.03x 0.99x 1.33x 1.70x 3.00x
Quick Ratio 0.76x 1.05x 1.08x 0.98x 0.94x 1.28x 1.64x 2.93x
Revenue Growth (YoY) -11.9% +16.8% +11.6% +13.6% -11.4% -9.4% -9.5% +7.7%
Net Income Growth (YoY) -- -- -- -- -256.6% -- -- --
EPS Growth (YoY) -- -- -- -- -112.7% -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001503802) · from December 31, 2009 Data through June 30, 2026 · synced Nov 21, 2026, 05:15 UTC · Open in terminal